Effects of a chitosan scaffold containing TGF-beta1 encapsulated chitosan microspheres on in vitro chondrocyte culture.

The objectives of this study were (1) to develop a three-dimensional chitosan scaffold in combination with transforming growth factor-beta1 (TGF-beta1)-loaded chitosan microspheres and (2) to evaluate the effect of the TGF-beta1 release on the chondrogenic potential of rabbit chondrocytes in the scaffolds. TGF-beta1 was loaded into chitosan microspheres using an emulsion-crosslinking method, resulting in spherical shapes with a size ranging from 0.3 to 1.5 microm. Controlled release of TGF-beta1, as measured by enzyme-linked immunosorbent assay (ELISA), was observed with chitosan microspheres over 7 days. Chitosan solutions (2% and 3%) were fabricated into two types of scaffolds with different pore morphologies and mechanical properties using a freeze-drying technique, with the result that scaffold with higher concentrations showed smaller pores and lower porosity, leading to a much stronger scaffold. The TGF-beta1 microspheres were incorporated into the scaffolds at a concentration of 10 ng TGF-beta1/scaffold and then chondrocytes seeded into each scaffold and incubated in vitro for 2 weeks. The 2% chitosan scaffolds showed higher cell attachment levels than the 3% chitosan scaffolds (P < 0.01), regardless of the TGF-beta1 microspheres. Both the proliferation rate and glycosaminoglycan (GAG) production were significantly higher for scaffolds incorporating TGF-beta1 microspheres than for the control scaffolds without microspheres 10 days after incubation. Extracellular matrix staining by Safranin O and immunohistochemistry for type II collagen both significantly increased in scaffolds containing TGF-beta1 microspheres. These results suggest that the TGF-beta1 microsphere incorporated in scaffolds have the potential to enhance cartilage formation.

[1]  Ick Chan Kwon,et al.  Preparation of sodium alginate microspheres containing hydrophilic β-lactam antibiotics , 1996 .

[2]  Freddie H. Fu,et al.  GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesisNo benefit of any kind will be received either directly or indirectly by the authors. , 2000 .

[3]  T. Chandy,et al.  Chitosan--as a biomaterial. , 1990, Biomaterials, artificial cells, and artificial organs.

[4]  J. Suh,et al.  Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. , 2000, Biomaterials.

[5]  I. Kwon,et al.  Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[6]  O. Damour,et al.  Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties. , 1998, Biomaterials.

[7]  Tom Minas,et al.  Current concepts in the treatment of articular cartilage defects. , 1997, Orthopedics.

[8]  S. Madihally,et al.  Porous chitosan scaffolds for tissue engineering. , 1999, Biomaterials.

[9]  Joong,et al.  The in vitro effects of dehydroepiandrosterone on human osteoarthritic chondrocytes. , 2003, Osteoarthritis and cartilage.

[10]  A J Nixon,et al.  Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor beta-1. , 1997, American journal of veterinary research.

[11]  H J Mankin,et al.  Articular cartilage: tissue design and chondrocyte-matrix interactions. , 1998, Instructional course lectures.

[12]  Y Ikada,et al.  Fabrication of porous gelatin scaffolds for tissue engineering. , 1999, Biomaterials.

[13]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[14]  R. Muzzarelli,et al.  Osteoconductive properties of methylpyrrolidinone chitosan in an animal model. , 1993, Biomaterials.

[15]  D. Hungerford,et al.  Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. , 2000, Journal of biomedical materials research.

[16]  A. Mikos,et al.  Review: tissue engineering for regeneration of articular cartilage. , 2000, Biomaterials.

[17]  Q. Myrvik,et al.  Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice , 1997, Infection and immunity.

[18]  K. Zhu,et al.  Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. , 2001, Journal of microencapsulation.

[19]  J. Mao,et al.  Structure and properties of bilayer chitosan-gelatin scaffolds. , 2003, Biomaterials.

[20]  J. Verhaar,et al.  Growth factors in cartilage tissue engineering. , 2002, Biorheology.

[21]  Robert Langer,et al.  Controlled‐release of IGF‐I and TGF‐β1 in a photopolymerizing hydrogel for cartilage tissue engineering , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  L. Illum,et al.  Chitosan and its use as a pharmaceutical excipient. , 1998, Pharmaceutical research.

[23]  A. Mikos,et al.  Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Mark Saltzman W,et al.  Materials for protein delivery in tissue engineering. , 1998, Advanced drug delivery reviews.

[25]  A. Mikos,et al.  Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .

[26]  G. Vunjak‐Novakovic,et al.  Growth factors for sequential cellular de- and re-differentiation in tissue engineering. , 2002, Biochemical and biophysical research communications.

[27]  M. Nimni Polypeptide growth factors: targeted delivery systems. , 1997, Biomaterials.

[28]  E. Fu,et al.  Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. , 2003, Biochemical and biophysical research communications.

[29]  I. Kwon,et al.  Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[30]  M. Murakami,et al.  Evaluation effects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages. , 2001, Biomaterials.

[31]  M J Yaszemski,et al.  Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. , 2000, Journal of biomedical materials research.

[32]  C. Malemud,et al.  The role of growth factors in cartilage metabolism. , 1993, Rheumatic diseases clinics of North America.

[33]  E. Edelman,et al.  Cellular Response to Transforming Growth Factor-β1 and Basic Fibroblast Growth Factor Depends on Release Kinetics and Extracellular Matrix Interactions* , 1996, The Journal of Biological Chemistry.

[34]  Lonnie D Shea,et al.  Drug-releasing scaffolds fabricated from drug-loaded microspheres. , 2002, Journal of biomedical materials research.

[35]  K. Yao,et al.  Biomimetic surface modification of poly(L-lactic acid) with chitosan and its effects on articular chondrocytes in vitro. , 2003, Biomaterials.

[36]  K. Zhu,et al.  Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. , 2002, International journal of pharmaceutics.